Indefinite Delivery Contract SPE2DB22D3102

Award Date 3/16/22
Last Date to Order 11/25/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • 5.9K
    Federal Contract Awards

The Defense Logistics Agency awarded multiple delivery orders against an indefinite-delivery/indefinite-quantity contract to Amerisourcebergen Drug Corporation for pharmaceutical products and medical supplies. Amerisourcebergen will provide a range of medications, vaccines, and other commodities from its facility in Conshohocken, Pennsylvania to support the Department of Defense's worldwide health services. Delivery orders awarded between September 2023 and November 2025 have a combined value of approximately $999,999,999 and authorize the contractor to deliver items through the last date to order of November 25, 2025.

The Defense Logistics Agency functions as the logistics combat support agency for the Department of Defense, maintaining readiness by procuring and distributing medical material to military treatment facilities, combatant commands, and other government partners. Delivery orders described here were awarded under the agency's Pharmaceutical Prime Vendor program and authorize Amerisourcebergen to provide various prescription drugs, vaccines including for COVID-19, and medical consumables on an as-needed basis to fulfill the Defense Logistics Agency's stockpile and direct delivery requirements. No socioeconomic set-asides were applied to these orders, which utilize firm-fixed price and indefinite-delivery/indefinite-quantity contract types.

Generated 1/4/24, 9:40 PM